GW&K Investment Management, LLC - BIOHAVEN PHARMACTL HLDG CO L ownership

BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 133 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2018. The put-call ratio across all filers is 0.63 and the average weighting 1.3%.

Quarter-by-quarter ownership
GW&K Investment Management, LLC ownership history of BIOHAVEN PHARMACTL HLDG CO L
ValueSharesWeighting
Q3 2022$18,000
-86.2%
116
-87.0%
0.00%
-100.0%
Q2 2022$130,000
-99.7%
892
-99.8%
0.00%
-99.8%
Q1 2022$48,170,000
-8.1%
406,256
+6.8%
0.43%
-2.1%
Q4 2021$52,428,000
+385.4%
380,437
+389.3%
0.44%
+356.2%
Q3 2021$10,801,000
+7.6%
77,758
-24.8%
0.10%
+10.3%
Q2 2021$10,035,000
+38.9%
103,364
-2.2%
0.09%
+29.9%
Q1 2021$7,225,000
-16.6%
105,712
+4.5%
0.07%
-26.4%
Q4 2020$8,666,000
+11.7%
101,112
-15.3%
0.09%
-10.8%
Q3 2020$7,758,000
+10.5%
119,340
+24.3%
0.10%
+3.0%
Q2 2020$7,022,000
+56.3%
96,041
-27.3%
0.10%
+25.3%
Q1 2020$4,493,000
-41.1%
132,037
-5.7%
0.08%
-22.5%
Q4 2019$7,624,000
+24.8%
140,046
-4.3%
0.10%
+18.6%
Q3 2019$6,107,000
+34.8%
146,376
+41.5%
0.09%
+24.6%
Q2 2019$4,531,000
-15.9%
103,480
-1.1%
0.07%
-20.7%
Q1 2019$5,388,000
+20.1%
104,679
-13.7%
0.09%
-2.2%
Q4 2018$4,486,000121,3060.09%
Other shareholders
BIOHAVEN PHARMACTL HLDG CO L shareholders Q4 2018
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 896,844$123,594,00067.92%
RP Management, LLC 1,111,111$153,122,00064.09%
ORACLE INVESTMENT MANAGEMENT INC 2,075,402$286,011,00040.64%
ARS Investment Partners, LLC 463,392$63,860,0005.86%
KINGDON CAPITAL MANAGEMENT, L.L.C. 300,373$41,394,0004.76%
SILVERARC CAPITAL MANAGEMENT, LLC 80,348$11,073,0004.49%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 139,900$19,282,0004.30%
Avidity Partners Management LP 1,140,000$157,103,0003.33%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$27,562,0003.17%
Eventide Asset Management 1,635,000$225,319,0002.88%
View complete list of BIOHAVEN PHARMACTL HLDG CO L shareholders